Exclusive to Med-ERRS, our EVALUATE-ERR® service looks at a unique aspect of a product, such as a
dosage form, special packaging, or trademark. We employ
Failure Mode and Effects Analysis
(FMEA) to determine which path or choice to follow to minimize the risk of error and provide
specific recommendations and error-reduction strategies.
We have also performed the EVALUATE-ERR® service in response to specific FDA requests or to fulfill a
Risk Evaluation and Mitigation Strategy (REMS).
The EVALUATE-ERR® service might be used by pharmaceutical companies wishing to choose between the
use of a dual trademark or the original trademark with a modifier (suffix) for a new product in their
existing product line.
Safety Issue: Family Tradenames